BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7192600)

  • 1. Relationship between adenosine deaminase and a human thymus leukemia antigen isolated from MOLT 4 cells.
    Dowell BL; Segars JH; Metzgar RS
    Cancer Res; 1981 Jan; 41(1):343-5. PubMed ID: 7192600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human thymus-leukemia-associated antigen as a low-molecular-weight form of adenosine deaminase.
    Chechik BE; Schrader WP; Daddona PE
    J Natl Cancer Inst; 1980 May; 64(5):1077-83. PubMed ID: 6767872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of human thymocytes and a malignant T-lymphoblast cell line, MOLT-3.
    Okamura S; Chechik BE; Lee C; Gelfand EW; Mak TW
    Cancer Res; 1981 May; 41(5):1664-8. PubMed ID: 6971148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC; Fishman M; Look T
    J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunomorphologic study of adenosine deaminase distribution in human thymus tissue, normal lymphocytes, and hematopoietic cell lines.
    Chechik BE; Schrader WP; Minowada J
    J Immunol; 1981 Mar; 126(3):1003-7. PubMed ID: 7007497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple forms of adenosine deaminase in the thymus of the bovine fetus and calf].
    Rotondaro L
    Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2355-60. PubMed ID: 7337749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human, rat and mouse adenosine deaminase by immunochemical and immunomorphologic methods using antiserum to calf enzyme.
    Chechik BE; Sengupta S
    J Immunol Methods; 1981; 45(2):165-76. PubMed ID: 6793662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.
    Smyth JF; Poplack DG; Holiman BJ; Leventhal BG; Yarbro G
    J Clin Invest; 1978 Sep; 62(3):710-2. PubMed ID: 308513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and some properties of adenosine deaminase from human thymus.
    SenGupta S; Schrader WP; Chechik BE
    Prep Biochem; 1982; 12(4):323-40. PubMed ID: 7156058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azacytidine-induced reactivation of adenosine deaminase in a murine cytotoxic T cell line.
    Castellazzi M; Vielh P; Longacre S
    Eur J Immunol; 1986 Sep; 16(9):1081-6. PubMed ID: 2428625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiation and ADA (adenosine deaminase) isozymes].
    Kurata N; Kihara M
    Rinsho Byori; 1989 Mar; 37(3):336-8. PubMed ID: 2746924
    [No Abstract]   [Full Text] [Related]  

  • 12. The distribution of adenosine deaminase among lymphocyte populations in the rat.
    Barton R; Martiniuk F; Hirschhorn R; Goldschneider I
    J Immunol; 1979 Jan; 122(1):216-20. PubMed ID: 310828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human thymus/leukaemia-associated antigen (a low-molecular weight form of adenosine deaminase) and the phenotype of leukaemic cells.
    Chechik BE; Rao J; Greaves MF; Hoffbrand AV
    Leuk Res; 1980; 4(4):343-9. PubMed ID: 6997639
    [No Abstract]   [Full Text] [Related]  

  • 14. A flow cytometric method for the detection of adenosine deaminase in mononuclear cells.
    SenGupta S; Petsche D; Gelfand EW; Chechik BE
    J Immunol Methods; 1985 Jun; 80(2):155-62. PubMed ID: 3925020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines.
    Smith SD; Shatsky M; Cohen PS; Warnke R; Link MP; Glader BE
    Cancer Res; 1984 Dec; 44(12 Pt 1):5657-60. PubMed ID: 6437672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase and terminal deoxynucleotidyl transferase: biochemical markers in the management of chronic myelogenous leukemia.
    Grever MR; Coleman MS; Balcerzak SP
    Cancer Res; 1983 Mar; 43(3):1442-5. PubMed ID: 6572097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase positive, E receptor negative lymphoma.
    Gordon EM; Gross S; Altman A
    Am J Pediatr Hematol Oncol; 1982; 4(2):135-9. PubMed ID: 6981356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase complexing protein (ADCP): a transformation sensitive protein with potentials of a cancer marker.
    Herbschleb-Voogt E; Ten Kate J; Meera Khan P
    Anticancer Res; 1983; 3(2):95-100. PubMed ID: 6133497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient stimulatory adenosine deaminase activity in peripheral lymphocyte lysates from a case of T-cell lymphoma.
    Kedar A; Tritsch GL; Freeman AI
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):153-62. PubMed ID: 6893085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase activity in thymus and other human tissues.
    Adams A; Harkness RA
    Clin Exp Immunol; 1976 Dec; 26(3):647-9. PubMed ID: 1009688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.